The KRT2 gene makes keratin 2, a protein that helps the upper layers of skin stay strong and handle everyday rubbing. This gene helps your body keep the skin barrier more stable, so certain variants can lead to fragile skin, blistering, peeling, and scaly patches, often starting in infancy. People with a KRT2-related skin condition are usually described as having superficial epidermolytic ichthyosis. KRT2 is mainly known in dermatology and has not drawn the same public attention as genes like BRCA1 or APOE.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medications. To go further into this topic, you can find more in the LearnHub.
Overview
KRT2Gene function
What if the gene works
The KRT2 gene helps make a skin protein that gives the outer skin layers strength and flexibility. This helps skin cells stay intact during rubbing and everyday wear.
Risk
What if the gene does not work
Variants in the KRT2 gene mainly cause superficial epidermolytic ichthyosis, with fragile skin, blistering, peeling, and later thickened rough patches. Milder and more severe variants can influence when symptoms start and how noticeable they are.
Treatment
What does that mean for your treatment
No KRT2-specific treatment or drug choice is currently established. Care is guided by skin symptoms, using standard skin treatments such as moisturizers and other supportive measures rather than the exact KRT2 variant.
Conditions associated with KRT2
Gene function
What if the gene works
Your outer skin faces constant rubbing, stretching, and renewal. The KRT2 gene helps upper skin cells stay strong as they flatten and become part of the skin’s surface. Its protein forms part of an internal support network that keeps these cells steady during everyday wear.
Inside upper skin cells, the KRT2 gene helps build strong support fibers. This internal framework helps cells keep their shape and stay resilient during normal movement and contact.
As skin cells move upward, the KRT2 gene supports the final steps of forming the outer skin layer. This is a key part of KRT2 gene function in skin, where cells need to stay organized to create a durable surface.
The protein made from the KRT2 gene works with other keratin proteins to create strong fibers inside skin cells. Together, these fibers help the skin’s surface handle rubbing, washing, and pressure as part of daily life.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal differences among people, including appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KRT2 gene can change the shape of keratin 2, so the protein may not join properly with other keratin proteins to make strong support strands inside skin cells. This is how KRT2 gene variants affect skin cell stability. Some variants have a milder effect on strand strength, while more disruptive variants can make cells more fragile and are often linked to earlier or more noticeable peeling and blistering.
How variants are linked to conditions
Pathogenic variants in the KRT2 gene cause superficial epidermolytic ichthyosis, a skin condition with blistering in infancy and later dry, thickened, peeling skin. This KRT2 gene skin condition was historically called ichthyosis bullosa of Siemens. Severity can vary even within families, but a confirmed pathogenic variant in the KRT2 gene supports the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when more than one gene and environmental influences are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KRT2, the main risk comes from having a disease-causing gene change, usually inherited from a parent or arising for the first time in a child. Heat, rubbing, and skin irritation can make blistering and peeling worse, but they do not change whether the condition develops.
Inheritance of KRT2 variants
Variants in the KRT2 gene are usually inherited in an autosomal dominant pattern, which means a child can inherit the condition if just one parent carries the variant. If a parent has a disease-causing KRT2 gene variant, each pregnancy has a 50% chance of passing it on. Some people with KRT2-related skin conditions have a new (de novo) variant, meaning it started in them and was not inherited from either parent. This is the established pattern for KRT2 gene inheritance in the well-known skin conditions linked to this gene.
What does my KRT2 result mean for my family?
For KRT2, the best-known family pattern is dominant, which means a result linked to a KRT2-related skin condition can sometimes also be found in close relatives such as a parent, brother, sister, or child. Family members who have fragile skin, blistering, or thickened, peeling skin may share the same change. Close relatives may want to talk with their doctor about whether the result could be relevant for them.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the KRT2 gene, doctors use genetic testing for KRT2 variants on a saliva sample, cheek swab, or blood sample. A laboratory reads the DNA code and compares it with the usual sequence to identify variants, which can help confirm whether KRT2 is involved.
When should I consider getting a genetic test?
Consider testing the KRT2 gene if there is ongoing skin blistering, peeling, or rough thickened skin that started in infancy or runs in the family. A KRT2 result can help confirm an inherited skin condition and clarify the chance of it being passed on to children.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines because the body absorbs, breaks down, and handles drugs in slightly different ways from one person to another. This helps explain why the same treatment works well for one person, seems weaker for someone else, or causes more side effects in another. These differences are common and can influence both how effective a medicine feels and how sensitive a person is to it. Medication response is shaped by genetics along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape the way a person responds to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more personalized. If you want to explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the KRT2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general health concerns or questions about medication side effects are best discussed with your doctor.
History
KRT2 entered medical genetics through research on inherited skin conditions marked by fragile, easily irritated skin. Initially understood only through visible traits, later recognized as tied to a specific gene, it became linked to a milder form of epidermolytic ichthyosis now often called superficial epidermolytic ichthyosis. In the 1990s, researchers identified disease causing variants in the KRT2 gene and showed that they affect the skin’s upper layers. This helped separate KRT2 related ichthyosis from similar conditions caused by changes in other keratin genes. With each decade, genetic studies refined the picture, making diagnosis more precise and improving the naming of these skin conditions.